최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.44 no.4, 2023년, pp.765 - 773
오유나 (휘림한방병원) , 박경덕 (휘림한방병원) , 정유진 (휘림한방병원) , 김지수 (휘림한방병원) , 정범진 (휘림한방병원) , 방선휘 (휘림한방병원)
Objective: This long-term case report details a case of pancreatic cancer with lung metastasis suppressed by integrative cancer medicine (IMT). Methods: A 64-year-old woman diagnosed with pancreatic cancer visited a Korean medicine hospital complaining about the side effects of chemotherapy for lung...
NIH. Cancer Stat Facts: Pancreatic Cancer.?Available from:https://seer.cancer.gov/statfacts/html/pancreas.html Accessed 19th September 2023.
Jung KW, Won YJ, Kang MJ, Kong HJ, Im?JS, Seo HG. Prediction of Cancer Incidence and?Mortality in Korea. Cancer Res Treat 2022;54(2):345-51.
Hong S, Won YJ, Park YR, Jung KW, Kong HJ,?Lee ES. Cancer statistics in Korea: incidence,?mortality, survival, and prevalence in 2017. Cancer?Res Treat 2020;52(2):335-50.
Committee of the Korean clinical practice guideline?for pancreatic cancer and National Cancer?Center, Korea. Korean clinical practice guideline?for pancreatic cancer 2021: A summary of?evidence-based, multi-disciplinary diagnostic and?therapeutic approaches. Pancreatology 2021;21(7):1326-41.
Conroy T, Desseigne F, Ychou M, Bouche O,?Guimbaud R, Becouarn Y, et al. FOLFIRINOX?versus gemcitabine for metastatic pancreatic?cancer. N Engl J Med 2011;364(19):1817-25.
Von Hoff DD, Ervin T, Arena FP, Chiorean EG,?Infante J, Moore M, et al. Increased Survival?in Pancreatic Cancer with nab-Paclitaxel plus?Gemcitabine. N Engl J Med 2013;369(18):1691-703.
Han GJ, Jeong HY, Park EJ, Lee AR, Lee JM,?Seong S, Kim SS. Review of Domestic Research?on Korean Medicine for Pancreatic Cancer. J?Int Korean Med 2019;40(1):70-88.
Ko EB, Jang KJ, Jang JY, Song MH, Shin KS.?A Case Report of Partial Remission of End-stage?Pancreatic Cancer Patient with Liver Metastasis?Treated with Chemotherapy and Integrated Medicine?Therapy. J Int Korean Med 2020;41(2):166-76.
Bang SH, Lee JH, Cho JH, Lee YW, Son CG,?Cho CK, et al. A Case Report of Pancreatic?Cancer Treated with Lymph Node Metastasis.?Korean J Orient Int Med 2007;28(4):948-55.
Joo HE, Kim JW, Park JH, Cho YM, Seo HS,?Ko EJ, et al. A Case Report of Traditional?Korean Medicine Based-Integrative Oncology?of Recurrent Pancreatic Cancer. J of Kor?Traditional Oncology 2022;27(1):1-12.
Mizrahi JD, Surana R, Valle JW, Shroff RT.?Pancreatic cancer. Lancet 2020;395(10242):2008-20.
Yoon HC, Kang JY, Kim JY, Joung JY, Son?CG, Lee NH, et al. Trends in Treatment with?and Mechanism of Moxibustion in Cancer?Patients: A Review. J Int Korean Med 2015;36(3):361-79.
Guo JQ, Zheng QH, Chen H, Chen L, Xu JB,?Chen MY, et al. Ginsenoside Rg3 inhibition of?vasculogenic mimicry in pancreatic cancer?through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression. Int J Oncol 2014;45(3):1065-72.
Bang JY, Kim EY, Shim TK, Yoo HS, Lee YW,?Kim YS, et al. Analysis of anti-angiogenic?mechanism of HangAmDan-B(HAD-B), a Korean?traditional medicine, using antibody microarray?chip. J Biochip 2000;4(4):350-5.
Kim JM, Park JW, Yoo HS, Lee YW, Cho CK.?Case Report of the Pancreatic Cancer Patient?after Pancreatoduodenectomy who is Taking?the HangAm-Plus to Anti-metastasis and?Preventing Recurrence. J of Kor Traditional?Oncology 2011;16(1):33-9.
Bottger F, Valles-Marti A, Cahn L, Jimenez CR.?High-dose intravenous vitamin C, a promising?multi-targeting agent in the treatment of cancer.?J Exp Clin Cancer Res 2021;40(1):343.
Thronicke A, Schad F, Debus M, Grabowski J,?Soldner G. Viscum album L. Therapy in Oncology:?An Update on Current Evidence. Complement?Med Res 2022;29(4):362-8.
Wei Y, Zhang Y, Li P, Yan C, Wang L. Thymosin?α-1 in cancer therapy: Immunoregulation and?potential applications. Int Immunopharmacol?2023;117:109744.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.